<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR139">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhuang</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Fan</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Chu</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Shen</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Guo</surname>
    <given-names>G</given-names>
   </name>
  </person-group>
  <article-title>Chinese patent medicines in the treatment of coronavirus disease 2019 (COVID-19) in China</article-title>
  <source>Front Pharmacol</source>
  <year>2020</year>
  <volume>11</volume>
  <fpage>1066</fpage>
  <pub-id pub-id-type="doi">10.3389/fphar.2020.01066</pub-id>
  <?supplied-pmid 7396557?>
  <pub-id pub-id-type="pmid">32848729</pub-id>
 </element-citation>
</ref>
